{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T12:11:18Z","timestamp":1670069478889},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.arcped.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T12:59:05Z","timestamp":1466773145000},"page":"857-866","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Maladie osseuse li\u00e9e \u00e0 la mucoviscidose\u00a0: mise au point"],"prefix":"10.1016","volume":"23","author":[{"given":"C.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2016.05.001_bib0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/MCP.0b013e3283659e35","article-title":"Cystic fibrosis-related bone disease","volume":"19","author":"Paccou","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2005.04.015","article-title":"Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents","volume":"147","author":"Rovner","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0015","first-page":"1","volume":"17","author":"National Institutes of health","year":"2000"},{"key":"10.1016\/j.arcped.2016.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-009-9316-9","article-title":"The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis","volume":"86","author":"Paccou","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arcped.2016.05.001_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0022-3476(94)70194-6","article-title":"Kyphosis and fractures in children and young adults with cystic fibrosis","volume":"125","author":"Henderson","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fped.2014.00011","article-title":"Thoracic kyphosis is now uncommon amongst children and adolescents with cystic fibrosis","volume":"2","author":"Barker","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcf.2008.02.001","article-title":"Exercise during childhood and adolescence: a prophylaxis against cystic fibrosis-related low bone mineral density?: exercise for bone health in children with cystic fibrosis","volume":"7","author":"Hind","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archpedi.1979.02130060072016","article-title":"Demineralization in cystic fibrosis detected by direct photon absorptiometry","volume":"133","author":"Mischler","year":"1979","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.arcped.2016.05.001_bib0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcf.2015.01.011","article-title":"Trends in bone mineral density in young adults with cystic fibrosis over a 15\u00a0year period","volume":"14","author":"Putman","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prrv.2009.05.001","article-title":"Update on cystic fibrosis-related bone disease: a special focus on children","volume":"10","author":"Sermet-Gaudelus","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.arcped.2016.05.001_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00247-009-1446-8","article-title":"Bone mineral and body composition alterations in paediatric cystic fibrosis patients","volume":"40","author":"Reix","year":"2009","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.arcped.2016.05.001_bib0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/rccm.200606-776OC","article-title":"Low bone mineral density in young children with cystic fibrosis","volume":"175","author":"Sermet-Gaudelus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.arcped.2007.12.003","article-title":"Recommandations pour la prise en charge de la d\u00e9min\u00e9ralisation osseuse dans la mucoviscidose","volume":"15","author":"Sermet-Gaudelus","year":"2008","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jcf.2014.07.011","article-title":"Cystic fibrosis-related bone disease explored using a four step algorithm","volume":"14","author":"Brookes","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.arcped.2009.08.004","article-title":"Nouvelles techniques d\u2019imagerie osseuse\u00a0: application chez l\u2019enfant atteint de maladie r\u00e9nale chronique","volume":"16","author":"Bacchetta","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jocd.2014.01.002","article-title":"Bone densitometry in infants and young children: the 2013\u00a0ISCD pediatric official positions","volume":"17","author":"Kalkwarf","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.arcped.2016.05.001_bib0085","doi-asserted-by":"crossref","first-page":"e80098","DOI":"10.1371\/journal.pone.0080098","article-title":"Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease","volume":"8","author":"Stalvey","year":"2013","journal-title":"PLoS ONE"},{"issue":"Suppl. 2","key":"10.1016\/j.arcped.2016.05.001_bib0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1569-1993(11)60020-9","article-title":"Mouse models of cystic fibrosis: phenotypic analysis and research applications","volume":"10","author":"Wilke","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0095","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bone.2004.05.021","article-title":"Severe osteopenia in CFTR-null mice","volume":"35","author":"Dif","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.arcped.2016.05.001_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.200705-659OC","article-title":"Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator\u2013deficient mice","volume":"177","author":"Haston","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/PDR.0b013e3181961e80","article-title":"Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation","volume":"65","author":"Pashuck","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.arcped.2016.05.001_bib0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcf.2010.05.001","article-title":"Osteopenia in Cftr-deltaF508\u00a0mice","volume":"9","author":"Paradis","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0115","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ajpath.2012.01.039","article-title":"The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation","volume":"180","author":"Le Henaff","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcped.2016.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.bone.2009.12.002","article-title":"The cystic fibrosis transmembrane regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells","volume":"46","author":"Bronckers","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.arcped.2016.05.001_bib0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcf.2009.11.005","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2\u00a0in human bone","volume":"9","author":"Le Heron","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0130","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1378\/chest.118.2.434","article-title":"Bone histomorphometry in adult patients with cystic fibrosis","volume":"118","author":"Haworth","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.arcped.2016.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1164\/rccm.200206-578OC","article-title":"Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis","volume":"166","author":"Elkin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2478\/ams-2013-0011","article-title":"Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis","volume":"58","author":"Ambroszkiewicz","year":"2013","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.arcped.2016.05.001_bib0145","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2016.05.001_bib0150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00198-003-1388-1","article-title":"Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls","volume":"14","author":"Greer","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcped.2016.05.001_bib0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1378\/chest.10-2114","article-title":"Appropriate goal level for 25-hydroxyvitamin d in cystic fibrosis","volume":"140","author":"West","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.arcped.2016.05.001_bib0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcf.2009.11.007","article-title":"Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis","volume":"9","author":"Shead","year":"2010","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.arcped.2016.05.001_bib0175","first-page":"926045","article-title":"A roadmap to the brittle bones of cystic fibrosis","volume":"2011","author":"Gore","year":"2010","journal-title":"J Osteoporos"},{"key":"10.1016\/j.arcped.2016.05.001_bib0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature10763","article-title":"The contribution of bone to whole-organism physiology","volume":"481","author":"Karsenty","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.arcped.2016.05.001_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0022-3476(98)70172-6","article-title":"Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study","volume":"133","author":"Bhudhikanok","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcped.2016.05.001_bib0190","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/adc.84.6.516","article-title":"Bone status in cystic fibrosis","volume":"84","author":"Sood","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.arcped.2016.05.001_bib0195","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00198-011-1824-6","article-title":"Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects","volume":"23","author":"Bousson","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arcped.2016.05.001_bib0200","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2014-1982","article-title":"Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis","volume":"99","author":"Putman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2016.05.001_bib0205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1378\/chest.130.2.539","article-title":"Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density","volume":"130","author":"Stephenson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.arcped.2016.05.001_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2011.10.004","article-title":"Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis","volume":"11","author":"De Schepper","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcf.2012.10.006","article-title":"Quantitative bone ultrasound in pediatric patients with cystic fibrosis","volume":"12","author":"Pedrera-Zamorano","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"Suppl. 2","key":"10.1016\/j.arcped.2016.05.001_bib0220","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0225","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jcf.2011.10.001","article-title":"Inflammatory and growth factor response to continuous and intermittent exercise in youth with cystic fibrosis","volume":"11","author":"Nguyen","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0230","first-page":"CD007298","article-title":"Vitamin D supplementation for cystic fibrosis","volume":"5","author":"Ferguson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2016.05.001_bib0235","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the cystic fibrosis foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2016.05.001_bib0240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcf.2007.11.006","article-title":"Undercarboxylated osteocalcin and bone mass in 8\u201312\u00a0year old children with cystic fibrosis","volume":"7","author":"Fewtrell","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arcped.2016.05.001_bib0245","first-page":"CD008482","article-title":"Vitamin K supplementation for cystic fibrosis","volume":"1","author":"Jagannath","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2016.05.001_bib0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-2600(13)70064-X","article-title":"Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate","volume":"1","author":"Bianchi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arcped.2016.05.001_bib0255","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"3","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arcped.2016.05.001_bib0260","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40200-014-0109-y","article-title":"Bisphosphonate therapy in pediatric patients","volume":"13","author":"Eghbali-Fatourechi","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.arcped.2016.05.001_bib0265","first-page":"893589","article-title":"Evaluation of teriparatide for treatment of osteoporosis in four patients with cystic fibrosis: a case series","volume":"2014","author":"Siwamogsatham","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/j.arcped.2016.05.001_bib0270","first-page":"232","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","volume":"14","author":"Thaker","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.arcped.2016.05.001_bib0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0004-27302010000200007","article-title":"Osteoporosis and inflammation","volume":"54","author":"Lacativa","year":"2010","journal-title":"Arq Bras Endocrinol Amp Metabol"},{"key":"10.1016\/j.arcped.2016.05.001_bib0280","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1183\/09031936.00174014","article-title":"Cystic fibrosis bone disease: is the CFTR corrector C18\u00a0an option for therapy?","volume":"45","author":"Velard","year":"2015","journal-title":"Eur Respir J"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X1630238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X1630238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T21:29:02Z","timestamp":1536614942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X1630238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0929693X1630238X"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2016.05.001","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maladie osseuse li\u00e9e \u00e0 la mucoviscidose\u00a0: mise au point","name":"articletitle","label":"Article Title"},{"value":"Archives de P\u00e9diatrie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcped.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}